Sort
15,842 grants matching “pancreatic cancer”
Noncovalent interaction of mutant KRAS inhibitors
$411,152Jen-Tsan Ashley Chi · Duke University · R21 · FY2025 · CA
PQ6: Therapeutic approaches for autonomic and neuroendocrine dysfunction in cancer cachexia
$411,136Aaron Grossberg · Oregon Health & Science University · R01 · FY2024 · CA
MEK AND PI3K INHIBITION IN THE REGULATION OF PANCREATIC CANCER METABOLISM
$411,122Lewis C Cantley · University Of Tx Md Anderson Can Ctr · P01 · FY2014 · CA
IMPACT OF NONCODING SATELLITE REPEATS ON PANCREATIC CANCER METASTASIS
$410,940The General Hospital Corporation · · FY2013 · Department of Defense
A Multifaceted Radiomics Model to Predict Cervical Lymph Node Metastasis for Involved Nodal Radiation Therapy
$410,620Jing Wang · Ut Southwestern Medical Center · R01 · FY2022 · CA
Basis for Lymphomagenesis in Akt2 Transgenic Mice
$410,451Joseph Robert Testa · Fox Chase Cancer Center · R01 · FY2012 · CA
Project 4: Translation and preclinical studies of a personalized pancreas cancer vaccine
$410,431William E Gillanders · Washington University · P50 · FY2020 · CA
Mechanisms of immunotherapy response and resistance in pancreatic ductal adenocarcinoma
$410,395Ingunn Margarete Stromnes · University Of Minnesota · R01 · FY2024 · CA
Project 3 : Diagnosis and Management of Pancreatic Cysts
$410,388Anne Marie Lennon · Johns Hopkins University · P50 · FY2018 · CA
Unique Anti-microbial Rinse to Reduce Oral Inflammation
$410,355Charles J Gauntt · Biomedical Development Corporation · R44 · FY2010 · HL
The Development of Clinical Grade, Targeted Magnetic Nanoparticles
$410,276Ralph Weissleder · Massachusetts Institute Of Technology · U54 · FY2011 · CA
Mechanistic Dissection of the Falconi Anemia Pathway of DNA Damage Response and Repair
$410,163Patrick Sung · Yale University · R01 · FY2017 · CA
3D High Density Collagen I Improves Modeling of Metastatic Pancreatic Cancer
$410,115Rebekah White · University Of California, San Diego · R21 · FY2025 · CA
Molecular Mechanisms of Programmed Necrosis Execution
$410,000Ayaz Najafov · Ut Southwestern Medical Center · R35 · FY2025 · GM
Molecular Mechanisms of Programmed Necrosis Execution
$410,000Ayaz Najafov · Ut Southwestern Medical Center · R35 · FY2024 · GM
Centroacinar progenitors in mouse and zebrafish pancreas
$410,000Steven D Leach · Johns Hopkins University · R01 · FY2010 · DK
FUNCTIONAL GENOMICS OF THE DEVELOPING ENDOCRINE PANCREAS
$410,000Washington University · R24 · FY2000 · DK
Molecular Mechanisms of Programmed Necrosis Execution
$410,000Ayaz Najafov · Ut Southwestern Medical Center · R35 · FY2022 · GM
Molecular Mechanisms of Programmed Necrosis Execution
$410,000Ayaz Najafov · Ut Southwestern Medical Center · R35 · FY2023 · GM
CHARM 2: Chemotherapy for ablation and resolution of mucinous pancreatic cysts: a prospective, randomized, double-blind, multi-center clinical trial
$409,653Matthew T. Moyer · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2022 · CA
Project 1: Elucidating the genetics and cell of origin of pancreatic cancer initiation
$409,455Laura D Attardi · Stanford University · P01 · FY2023 · CA
Targeting cysteine import to induce ferroptotic cell death in pancreatic cancer
$409,428Kenneth P Olive · Columbia University Health Sciences · R01 · FY2022 · CA
The role of wild-type KRAS in the context of tumor profession and metastasis
$409,343Gloria Huei-Ting Su · Columbia University Health Sciences · R01 · FY2015 · CA
ELUCIDATION & MODULATION OF NATURAL KILLER CELL SIGNALING: APPLICATION IN CANCER
$409,266Michael A Caligiuri · Ohio State University · P01 · FY2011 · CA
Ferroptosis, Cellular Metabolism, and Cancer
$409,226Xuejun Jiang · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA